It's time for Parkinson's research to move out of the slow lane
Parkinson's research and development moves far too slowly, says columnist Doc Irish, who argues for a more innovative and dynamic system.| Parkinson's News Today
Parkinson's research and development moves far too slowly, says columnist Doc Irish, who argues for a more innovative and dynamic system.| Parkinson's News Today
Seal Rock has joined an MJFF initiative to develop therapies targeting the LRRK2 gene, which can contribute to Parkinson’s development.| Parkinson's News Today
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
Insilico said it plans to ask the FDA this year for permission to move an AI-designed Parkinson's therapy into clinical trials.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
In a trial, once-daily buntanetap halted cognitive decline in early-stage Parkinson's and improved cognition in patients with mild dementia.| Parkinson's News Today
No description.| Parkinson's News Today
Margarida Maia is a science writer for Parkinson's News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Category archive page for News.| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today
UCF researchers have developed a biosensor that can rapidly detect and quantify dopamine levels in unprocessed blood samples.| Parkinson's News Today
Understanding and identifying epigenetic changes in blood samples from people with Parkinson’s disease may help assess the risk of dementia.| Parkinson's News Today
